https://www.selleckchem.com/pr....oducts/pkm2-inhibito
02; 95% CI, 1.01-1.03; P less then 0.001), a previous thromboembolic event (OR, 1.29; 95% CI, 1.01-1.65; P=0.04), nonpermanent AF (OR, 1.61; 95% CI, 1.34-1.93; P less then 0.001), and eGFR (OR, 1.22; 95% CI, 1.02-1.46; P=0.03). Between 2014 and 2018, an increase of patients treated with OACs, mainly with NOACs, was observed. Age, past thromboembolic complications, nonpermanent AF, and preserved renal function determined the choice of NOACs. The standard electrocardiogram (ECG) is commonly performed in the supine postu
Like
Comment
Share
